Clinical Trial Update: Phase 3 Study of SNF472 for Calciphylaxis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of SNF472 in calciphylaxis (calcific uremic arteriolopathy) has completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Calcific Uremic Arteriolopathy
• Calciphylaxis

Drugs mentioned

• SNF472 (SNF472)

Snippet

Sponsor: Sanifit Therapeutics S. A. | Conditions: Calciphylaxis, Calcific Uremic Arteriolopathy | Phase 3 | Status: COMPLETED | Results posted: 2024-02-20